(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NIKON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NIKON

ST13

US500000079252478

Class

1, 5, 10, 35, 39, 40, 42, 45

Filing

79252478

Registration

5958271

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

07/31/2026

Trademark type

Combined

Nice classes

1, 5, 10, 35, 39, 40, 42, 45

Filing date

07/27/2018

Registration date

01/14/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/31/2026

Last transaction

07/31/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

5

Owner type

98

Owner location

JP

Examiner

CROWLEY, SEAN MICHAEL

Law office

M70

Current location

TMO LAW OFFICE 116

Holders and representatives

Holders

N. C. (pessoa física)
N. C. (pessoa física)

Representatives

Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 1Class 5Class 10Class 35Class 39Class 40Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Industrial chemicals; chemicals for use in industry and science; lithography chemicals; photographic chemicals; chemicals for use in semiconductor manufacturing; industrial chemicals for research or scientific purposes; chemicals for use in biotechnological manufacturing processes and biotechnological product development; chemical reagents for non-medical purposes; chemical reagents for research or scientific purposes; chemical agents being industrial chemicals for research or scientific purposes; chemical agents for use in cell and tissue growth applicationsfor research and scientific purposes; bacterial preparationsother than for medical and veterinary use; cell growth media for growing biological cells; cell growth media for growing biological cells for research or scientific purposes; cell growth media for growing cells for use in scientific research; cells for research or scientific purposes; assays for research purposes

Class 5

Protein arrays for medical diagnostic use; proteins in the nature of enzymes for medical use; cells for medical use; microorganisms and cultures for medical use; cultures of microorganisms for medical use; culture media for use in cultivating humananimalplant cells; pharmaceutical preparations; pharmaceutical preparations for medical purposes used in chemotherapyimmunotherapygene therapy; pharmaceutical preparations for regenerative medical purposes; pharmaceutical preparations for gene therapy purposes; pharmaceutical preparations for chemotherapyimmunotherapy and gene therapy research and scientific purposes; semen for artificial insemination; cell culture reagents for medical or clinical medical use; sera and reagents for biological and pharmaceutical research and for the manufacture of pharmaceutical productsfor oncological; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; chemicals for medical purposes; chemicals for regenerative medical purposes; chemicals for gene therapy purposes; chemical reagents for medical purposes; chemical reagents for regenerative medical purposes; chemical reagents for gene therapy purposes; chemical agents for medical purposes; chemical agents for regenerative medical purposes; chemical agents for gene therapy purposes; cell growth media for growing biological cells for medical purposes; cell growth media for growing biological cells for regenerative medical purposes; cell growth media for growing biological cells for gene therapy purposes

Class 10

Medical surgical apparatus and surgical instruments and replacement parts and replacement fittings therefor; medical imaging apparatus; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for regenerative medical gene therapy purposes; medical apparatus and instruments for stem cell regenerative medical purposes; medical apparatus and instruments for gene therapy purposes; medical apparatus and instruments used for cell culture and replacement parts and replacement fitting therefor; medical apparatus and instruments used for cell culture and parts and fitting thereforbioreactors; cell culture apparatus for medical usecell culture chambers; cell culture apparatus for regenerative medical purposes being cell culture chambers; cell culture apparatus for regenerative medical purposestissue engineering chambers and bioreactors; cell culture apparatus for gene therapy purposes

Class 35

Retail store services featuring cells for research or scientific use; onlinetelephone and facsimile retail ordering services and mail order or electronic retail catalog services featuring cells for research or scientific use; retail store services featuring cells for medical use; onlinetelephone and facsimile retail ordering services and mail order or electronic retail catalog services featuring cells for medical use; business consultancy services relating to manufacturing

Class 39

Storage of cells; storage of cells for medical purposes; storage of cells for regenerative medical purposes; storage of cells for gene therapy purposes; storage of cells for research or scientific purposes; storage of goods; warehousing services; temporary safekeeping of personal belongings; cryogenic storage being biomedical servicesthe storage of human cells for medical use

Class 40

Custom production and processing of proteins and chemicals for others; custom manufacture of cells for others; custom manufacture of cells for medical purposes for others; custom manufacture of cells for regenerative medical purposes for others; custom manufacture of cells for gene therapy purposes for others; custom manufacture of cells for research or scientific purposes for others; custom manufacture of cell tissues for others; custom processing of cells for others; custom processing of cells for medical purposes for others; custom processing of cells for regenerative medical purposes for others; custom processing of cells for gene therapy purposes for others; custom processing of cells for research or scientific purposes for others; providing information and advices about manufacturing cells; providing information and advices about manufacturing cells for medical purposes; providing information and advices about manufacturing cells for regenerative medical purposes; providing information and advices about manufacturing cells for gene therapy purposes; providing information and advices about manufacturing cells for research or scientific purposes; custom manufacture and processing of chemicalschemical products and pharmaceuticals for others; custom manufacture and processing of cells for research or scientific use for others; processing of artificial limbs or artificial teethincluding processing of medical materials; production being manufacturing and processing of chemicalsingredients for pharmaceuticalscells for research and scientific purposes; manufacture of bacteriological culturesbuffer solutionreagents for others; cryogenic preservation

Class 42

Custom research and development for medical purposes for others; custom research and development of cell and gene therapy products; custom research and development for medical purposes for others; custom research and development for regenerative medical purposes for others; custom research and development for gene therapy purposes for others; custom research and development for research or scientific purposes for others; custom cultivation of cells and tissues for others in the nature of new product development; custom cultivation of cells and tissues for the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for medical purposes for others in the nature of new product development; custom cultivation of cells and tissues for medical purposes in the nature of the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for regenerative medical purposes for others in the nature of new product development; custom cultivation of cells and tissues for regenerative medical purposes in the nature of the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for gene therapy purposes for others in the nature of new product development; custom cultivation of cells and tissues in the nature of the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for research or scientific purposes for others in the nature of new product development; custom cultivation of cells and tissues in the nature of bioengineering for research or scientific purposes for others; testinginspection or research of cells and providing information and consultancy therefor; testinginspection or research of cells for medical purposes and providing information and consultancy therefor; testinginspection or research of cells for regenerative medical purposes and providing information and consultancy therefor; testinginspection or research of cells for gene therapy purposes and providing information and consultancy therefor; testinginspection or research of cells for research or scientific purposes and providing information and consultancy therefor; researchdevelopments and quality control of cells and consultancy therefor; researchdevelopments and quality control of cells for medical purposes and consultancy therefor; researchdevelopments and quality control of cells for regenerative medical purposes and consultancy therefor; researchdevelopments and quality control of cells for gene therapy purposes and consultancy therefor; researchdevelopments and quality control of cells for research or scientific purposes and consultancy therefor; quality control for others; consultancy services in the field of quality control; consultancy services in the fields of testinginspectionresearch or investigation of pharmaceuticals and chemicals; consultancy services about testinginspectionresearch or investigation of cells; consultancy services in the fields of testinginspectionresearch or investigation of cells for medical purpose; consultancy services in the fields of testinginspectionresearch or investigation of cells for regenerative medical purposes; consultancy services in the fields of testinginspectionresearch or investigation of cells for gene therapy purposes; consultancy services in the fields of testinginspectionresearch or investigation of cells for research or scientific purposes; providing information and consultancy services about testinginspection or research of pharmaceuticals; providing medical and scientific research information and consultancy services in the fields of testinginspection or research of pharmaceuticals; custom inspectionanalysisresearch and development of cells for research or scientific use for others; custom services in the fields of scientific testinginspectionresearch or investigation of pharmaceuticals and chemicals; custom inspectionanalysisresearchdevelopment and design of pharmaceutical agents or pharmaceuticals for others; providing information about inspectionanalysisresearchdevelopment and design of chemicalschemical products or proteins; providing medical and scientific research information in the fields of inspectionanalysisresearchdevelopment and design of chemicalschemical products or proteins; providing information about inspectionanalysisresearchdevelopment and design of pharmaceutical agents or pharmaceuticals; providing medical and scientific research information in the fields of inspectionanalysisresearchdevelopment and design of pharmaceutical agents or pharmaceuticals; research and development in the field of microorganisms and cells; research and development in the field of microorganisms and cells for medical purposes; research and development in the field of microorganisms and cells for regenerative medical purposes; research and development in the field of microorganisms and cells for gene therapy purposes; research and development in the field of microorganisms and cells for research or scientific purposes; conducting clinical trials for others; providing information about clinical trials; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of pharmaceuticals; testinginspection or research of pharmaceuticalscosmetics or foodstuffs; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testinginspection or research on agriculturelivestock breeding or fisheries; providing scientific and research information in the field of bioscience via a website; development and design of manufacturing methods and of testing methods; process monitoring for quality assurance

Class 45

Consultancy services relating to laws and manufacturing regulations; consultancy services relating to laws and medical regulations; legal consultation services; regulatory compliance consulting in the field of pharmaceuticals and biologies; * biologics * agencies for legal procedures relating to lawsuits or other legal issues; legal services; providing information in the field of legal standards in the field of manufacturing; advisory services relating to manufacturing regulatory affairs ; advice and consultancy services in the field of medical regulatory affairs

Publications

History of USPTO decisions and trademark events.

43 publications found

C71T

CANCELLED SECTION 71

07/31/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/24/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/14/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

08/19/2021

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

08/07/2021

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

02/09/2021

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

12/30/2020

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

12/16/2020

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

12/07/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/07/2020

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

10/16/2020

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

09/25/2020

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

09/25/2020

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

08/11/2020

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

08/10/2020

PLGL

ASSIGNED TO PARALEGAL

08/10/2020

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

06/12/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/22/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/23/2020

FIMP

FINAL DISPOSITION PROCESSED

04/23/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/14/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/29/2019

PUBO

PUBLISHED FOR OPPOSITION

10/29/2019

GPNX

NOTIFICATION PROCESSED BY IB

10/25/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/09/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/09/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/09/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/23/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/18/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/18/2019

ALIE

ASSIGNED TO LIE

09/13/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/09/2019

RFNT

REFUSAL PROCESSED BY IB

03/29/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/09/2019

RFRR

REFUSAL PROCESSED BY MPU

03/09/2019

MAFR

APPLICATION FILING RECEIPT MAILED

03/02/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/28/2019

CNRT

NON-FINAL ACTION WRITTEN

02/27/2019

DOCK

ASSIGNED TO EXAMINER

02/26/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/26/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/25/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/21/2019

Continuous trademark protection

Get notified about every new filing that threatens NIKON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.